Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-012928
Filing Date
2012-08-15
Accepted
2012-08-15 16:06:42
Documents
1
Period of Report
2012-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 11358
  Complete submission text file 0001179110-12-012928.txt   12748
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54647 | Film No.: 121037184

Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-902-0682
OvaScience, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances